← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
ADCBiologicstalePfizerthatPhase 2

Gemtuzumab Ozogamicin (Gemtuzumab Ozogamicin)

Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 0%임상시험 65상태 RECRUITING
ADCBiologicstaleEli Lilly and CompanyDXdPhase 1

Itraconazole (Itraconazole)

Ovarian Neoplasms; Endometrial Neoplasms · Fallopian Tube Cancer

#FallopianTubeCancer#ADC#Phase1#인기#항체약물접합체+5
효능 ORR 10.5%임상시험 65상태 RECRUITING
AntibodystaleAstraZenecavedotin combined with pembr…Phase 3

Durvalumab (MEDI4736, MEDI4736 (Durvalumab))

Non-Small-Cell Lung Carcinoma NSCLC · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase3#인기#항체+5
효능 ORR 36.3%임상시험 65상태 ACTIVE
AntibodystaleNovartisPhase 3

Ofatumumab (Ofatumumab)

Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma · Leukemia

#Leukemia#Antibody#Phase3#인기#항체+5
효능 ORR 78.4%임상시험 65상태 RECRUITING
ADCBiologicstaleHoffmann-La RochePhase 2

Xeloda (Xeloda)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#인기#항체약물접합체+2
효능 ORR 30%임상시험 65상태 RECRUITING
AntibodystaleAkeso-drivenPhase 2

cadonilimab (cadonilimab)

Metastatic HER2 Positive Gastroesophageal Junction Cancer · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#Antibody#Phase2#인기#항체+5
임상시험 65상태 RECRUITING
CGTBiologicstaleAmgenPhase 3

Asparaginase Erwinia chrysanthemi (Asparaginase Erwinia chrysanthemi, Asparaginase Erwinia chrysanthemi (recombinant)-rywn, recombinant)

Acute Lymphoblastic Leukemia; Acute Lymphoblastic Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase3#인기#세포유전치료+5
효능 ORR 18%임상시험 64상태 RECRUITING
ADCBiologicstaleDaiichi SankyoreleasePhase 1

DP1 (DS-8201a, DS-8201a (DP1))

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#인기#항체약물접합체+4
효능 ORR 79.7%임상시험 64상태 ACTIVE
ADCBiologicstaleCaicun ZhouSN-38, indicated by higher …Phase 2

Gefitinib (Gefitinib)

Non-small-cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 74.9%임상시험 64상태 ACTIVE
AntibodystaleBelfast Health and Social Care …Approved

Golimumab (Golimumab)

Psoriatic Arthritis; Psoriasis · Chronic Nonbacterial Osteomyelitis

#ChronicNonbacterialOsteomyelitis#Antibody#Approved#인기#항체+5
효능 ORR 0.27%임상시험 64상태 DISCONTINUED
ADCBiologicstaleAstraZenecaPhase 3

Pemetrexed/Cisplatin (Pemetrexed/Cisplatin)

Non-Small-Cell Lung Carcinoma NSCLC · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 87.5%임상시험 64상태 RECRUITING
ADCBiologicstaleAbbVie (prior sponsor, Abbott)SN-38, which is primarily c…Phase 1

Ritonavir (Ritonavir)

HIV Infections · Neoplasm Metastasis

#NeoplasmMetastasis#ADC#Phase1#인기#항체약물접합체+5
효능 ORR 8%임상시험 64상태 ACTIVE
ADCBiologicstaleChia Tai Tianqing Pharmaceutica…Deruxtecan in Patients With…Phase 3

Taxane (Taxane)

HER2-negative Breast Cancer; Advanced Breast Cancer · HER2

#HER2#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 36%임상시험 64상태 RECRUITING
AntibodystaleGenentech, Inc.Phase 3

Tiragolumab (Tiragolumab)

Multiple Myeloma; Non-Hodgkin Lymphoma · Urothelial Carcinoma

#UrothelialCarcinoma#Antibody#Phase3#인기#항체+5
효능 ORR 77.3%임상시험 64상태 ACTIVE
ADCBiologicstaleJiangsu Tasly Diyi Pharmaceutic…Phase 2

vinorelbine tartrate (vinorelbine tartrate)

Estrogen Receptor-negative Breast Cancer; Estrogen Receptor-positive Breast Cancer · Adult Lymphocyte Depletion Hodgkin Lymph

#AdultLymphocyteDepletionHodgkinL#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 32%임상시험 64상태 ACTIVE
ADCBiologicstaleSuzhou Transcenta Therapeutics …DM1) leading to diabetic ke…Phase 2

Albumin-Paclitaxel (Albumin-Paclitaxel)

Non-small Cell Lung Cancer Metastatic; First-line Treatment · Breast Cancer Early Stage Breast Cancer

#BreastCancerEarlyStageBreastCanc#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 79.5%임상시험 63상태 RECRUITING
ADCBiologicstaleSanofireleasePhase 2

Anthracycline (Anthracycline)

HER2-negative Breast Cancer; Advanced Breast Cancer · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 95%임상시험 63상태 RECRUITING
CGTBiologicstaleTcelltech Inc.sPhase 1

Anti-B7-H3 Chimeric Antigen Receptor T-Cell (CAR-T Cell, Anti-B7-H3 Chimeric Antigen Receptor T-Cell, Anti-B7-H3 Chimeric Antigen Receptor T-Cell (CAR-T Cell) Injection/TX103)

Solid Tumors · B7-H3

#B7-H3#CGT#Phase1#인기#세포유전치료+5
효능 ORR 67%임상시험 63상태 RECRUITING
ADCBiologicstaleSpectrum Pharmaceuticals, IncPhase 2

Anti-thymocyte globulin, rabbit (Anti-thymocyte globulin, rabbit)

Aplastic Anemia; Bone Marrow Failure Syndrome · Leukemia, Acute

#LeukemiaAcute#ADC#Phase2#인기#항체약물접합체+4
임상시험 63상태 RECRUITING
AntibodystaleRochePhase 3

atezolizumab (Tecentriq, Atezolizumab + Bevacizumab)

Venous Thrombosis · Gastric Adenocarcinoma

#GastricAdenocarcinoma#Antibody#Phase3#인기#항체+5
효능 ORR 49.3%임상시험 63상태 RECRUITING

10 / 177 페이지

← 이전다음 →